Which are new drugs approved this 1st quarter?
4 new drugs including ‘Aljaview Inj,’ a FutureChem’s diagnostic drug for Alzheimer’s disease, reportedly acquire approval in the last 1st quarter.
According to the Ministry of Food and Drug Safety’s Online Drug Library, 4 new drugs and 2 orphan drugs acquired approval in the 1st quarter.
1 of t...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.